Cochlear implantation has become a safe procedure-and, as result of refinements in devices and surgical techniques, complications are atypical.
The Unified Airway: Do We Fully Appreciate Its Impact in Otolaryngology?
CT Scanning of the Paranasal Sinuses: Indications, Utilization, and Radiation Risks
With improved technology, as well as increased availability and access, diagnostic imaging has become the fastest growing segment of health care spending, with estimates of 15% to 35% increases annually.
Sentinel Node Biopsy in Head and Neck Cancer: No Easy Answer
The Private Sector Pitches In for the Uninsured: Part 3 of a series
America’s health care safety net may be full of holes, but its doctors and hospitals are generously pitching in with charity care to fill some tears in that net.
Nuances in Rhinoplasty: Pearls and Pitfalls
“Accentuate the positive” was one of the pointers heard by the almost 200 otolaryngologists and surgeons who attended the Triological Society’s April 28 panel discussion on “Nuances in Rhinoplasty” at the Combined Otolaryngology Spring Meeting.
Watchful Waiting and OME
I would like to comment on your article Watchful Waiting May Be the Best Strategy, by Sheri Polley, in the November 2006 issue of ENToday.
Head and Neck Surgery: Meeting the Needs of the 21st Century
How can head and neck surgeons best meet the changing needs of patients and trainees in the 21st century?
Drug Marketing: Different Impacts on Different Physicians
Pharmaceutical company representatives (PCRs) are as ubiquitous in otolaryngologists’ offices as seasonal allergies and ear infections.
AMA’s Opt-Out Provision for Sale of Physician Prescribing Data Seen as First Step
Otolaryngologists agree with their fellow physicians who prescribe drugs-pharmaceutical companies have no business buying or using information on how and when they prescribe particular drugs, nor do they want to be confronted by pharmaceutical company representatives in their office about why they do or don’t prescribe that company’s products.